MAIA Biotechnology Inc./$MAIA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases. Its asset, ateganosine (THIO, also known as 6-thio-dG or 6-thio-deoxyguanosine), is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The treatment approach involves administering THIO followed by the immune checkpoint inhibitor Libtayo (cemiplimab), which is manufactured and commercialized by Regeneron.
Ticker
$MAIA
Sector
Primary listing
AMEX
Employees
13
Headquarters
Website
MAIA Metrics
BasicAdvanced
$75m
-
-$0.70
0.32
-
Price and volume
Market cap
$75m
Beta
0.32
52-week high
$3.19
52-week low
$0.87
Average daily volume
712k
Financial strength
Current ratio
1.662
Quick ratio
1.483
Profitability
Management effectiveness
Return on assets (TTM)
-152.76%
Return on equity (TTM)
-745.24%
Valuation
Price to book
20.16
Price to tangible book (TTM)
20.16
Price to free cash flow (TTM)
-2.113
Free cash flow yield (TTM)
-47.32%
Free cash flow per share (TTM)
-0.587
Growth
Earnings per share change (TTM)
-33.43%
3-year earnings per share growth (CAGR)
-26.39%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MAIA Biotechnology Inc. stock?
MAIA Biotechnology Inc. (MAIA) has a market cap of $75M as of April 29, 2026.
What is the P/E ratio for MAIA Biotechnology Inc. stock?
The price to earnings (P/E) ratio for MAIA Biotechnology Inc. (MAIA) stock is 0 as of April 29, 2026.
Does MAIA Biotechnology Inc. stock pay dividends?
No, MAIA Biotechnology Inc. (MAIA) stock does not pay dividends to its shareholders as of April 29, 2026.
When is the next MAIA Biotechnology Inc. dividend payment date?
MAIA Biotechnology Inc. (MAIA) stock does not pay dividends to its shareholders.
What is the beta indicator for MAIA Biotechnology Inc.?
MAIA Biotechnology Inc. (MAIA) has a beta rating of 0.32. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.